POSTHORAX Australia

For surgeons, nurses and procurement

The evidence, in full.

Most external chest supports have never been tested in a randomised trial. The Posthorax vest has been the subject of four — conducted in Austrian, German and Italian cardiac centres and published in peer-reviewed cardiothoracic journals — and is included in the 2024 systematic review and meta-analysis of thorax support vests.

Those four trials sit inside a wider programme — twelve non-industry-funded studies run between 2010 and 2018 in 12,512 patients, with documented clinical use now in seven countries. The cohort studies, service evaluations and guideline positions from that programme are summarised after the trials.

Summaries below are drawn from the published papers. Full texts and PDFs are available on request.

54%

Reduction in the relative risk of deep sternal complications with routine use1

4,864

Patients randomised across the four Posthorax trials1–4

2007–16

Enrolment period spanned by the published trial programme

2

Innovation awards: City of Vienna 2009, HSJ Efficiency in Medical Technology 2013

A cardiothoracic surgeon reading printed trial papers at a desk

The randomised trials

2013 · largest trial n = 2,539 · prospective randomised multicentre

Prevention of sternal wound complications after sternotomy

2,539 patients undergoing cardiac surgery via median sternotomy were randomised between September 2007 and March 2010 to receive a Posthorax vest or not, worn 24 hours a day for at least six weeks, with 90-day follow-up and intention-to-treat analysis. The authors report that routine use of the device reduces the relative risk of deep sternal complications by 54%, and attribute the effect to additional stability that prevents instability and infection of the sternum while allowing deeper breathing, because friction at the sternal edges is minimised.

Gorlitzer M, Wagner F, Pfeiffer S, Folkmann S, Meinhart J, Fischlein T, Reichenspurner H, Grabenwoeger M. Interactive CardioVascular and Thoracic Surgery 2013;17(3):515–522. doi:10.1093/icvts/ivt240 · PMID 23760221

2010 n = 1,560 · prospective randomised multicentre

Improvement of sternum-related complications with the Posthorax support vest

1,560 cases were randomised: 905 patients received a flexible dressing postoperatively and 655 received the Posthorax support vest. Over 90 days of follow-up, additional surgical procedures were significantly reduced in the vest group. The authors conclude the vest is a valuable adjunct for preventing sternum-related complications after cardiac surgery.

Gorlitzer M, Wagner F, Pfeiffer S, Folkmann S, Meinhart J, Fischlein T, Reichenspurner H, Grabenwöger M. Interactive CardioVascular and Thoracic Surgery 2010;10(5):714–718. doi:10.1510/icvts.2009.223305

2009 · first trial n = 455 · randomised, single centre

A newly designed thorax support vest prevents sternum instability after median sternotomy

The trial that introduced the device: 455 adult cardiac surgery patients were randomised postoperatively to external support with the Posthorax vest or no support, with sternal wound complications as the endpoint. Alongside the clinical result, biomechanical testing with pressure points at the thoracic wall showed a marked difference between an elastic bandage and the support vest — the basis of the anterior–posterior stabilisation argument.

Gorlitzer M, Folkmann S, Meinhart J, Poslussny P, Thalmann M, Weiss G, Bijak M, Grabenwoeger M. European Journal of Cardio-Thoracic Surgery 2009;36(2):335–339. doi:10.1016/j.ejcts.2009.01.038 · PMID 19272785

2017 · high-risk patients n = 310 · prospective randomised

Preventing mechanical complications of median sternotomy in patients at high risk

310 patients with predisposing factors for sternal dehiscence were randomised to receive the Posthorax vest or not. Endpoints included mechanical sternal complications, quality of sternal healing, re-operation rate, length of hospitalisation and re-admission for sternal complications. The authors report that use of the vest reduces post-sternotomy mechanical complications and improves sternotomy healing, clinical course and postoperative quality of life.

Caimmi PP, Sabbatini M, Kapetanakis EI, Cantone S, Ferraz MV, Cannas M, Tesler UF. Cardiology and Therapy 2017;6(1):41–51. doi:10.1007/s40119-016-0078-y · PMID 27995554 · open access

2024 · systematic review 6 RCTs · 5,826 patients

Thorax support vests to prevent sternal wound infections — a meta-analysis

A systematic review and meta-analysis of thorax support vests in cardiac surgery pooled six randomised controlled trials covering 5,826 adult patients, including the Posthorax trials above. It is the current highest tier of evidence on the question and the right starting point for a hospital evaluating external chest support.

Caldonazo T, Dell’Aquila M, Doenst T, Gaudino M, et al. Interdisciplinary CardioVascular and Thoracic Surgery 2024;38(4):ivae055.

Beyond the randomised trials

Cohort studies, hospital service evaluations, biomechanical testing and one national consensus guideline. These are lower tiers of evidence than the trials above and we label them as such — each is quoted as the centre or guideline group reported it.

Sweden

Karolinska University Hospital, Stockholm

In 978 patients, mediastinitis was reduced by 72% — the largest effect reported in the programme.

Switzerland

University Heart Center Zurich

1,689 patients: deep sternal wound infection reduced by 52%.

United Kingdom

University Hospital Southampton NHS

265 patients: deep sternal wound infection reduced by 43%.

Cohort · Germany

University Heart Center Hamburg

A cohort of 2,200 patients showed a 63% reduction in mediastinitis where the vest protocol was followed — the figure quoted by Prof. Wagner below.

Cohort · Italy

Salvatore Maugeri Foundation

Across 1,009 patients, none of those wearing the vest experienced a severe complication — deep sternal wound infection or dehiscence.

Guideline · Spain

SEICAV / SECTCV consensus, 2021

The Spanish consensus guidelines give a Level 2+ strong recommendation for postoperative sternal immobilisation systems in all major cardiac surgery, citing a fall in complications from 3.87% to 0.61%.6

Biomechanics · Austria

Pressure-sensor testing of the thoracic wall

The 2009 trial reported biomechanical testing with pressure points at the thoracic wall, showing a marked difference between an elastic bandage and the support vest — the basis of the anterior–posterior stabilisation argument.3 The manufacturer’s own mechanical study puts numbers on it: sensors on a thorax model and 27 volunteers measured up to four times the counter-pressure of a common flexible bandage, 8 Nm against 2 Nm.

Programme

Twelve studies, none industry-funded

Twelve clinical studies covering 12,512 patients in seven countries, none funded by the manufacturer, conducted between 2010 and 2018. Study list and papers on request.

From the investigators

“Consequent application of the Posthorax vest reduced deep sternal wound complications by 63%.”
Florian M. Wagner, MD PhD — University Heart Center Hamburg, Germany
“The findings proved a positive biomechanical effect of the support vest in the anteroposterior movement.”
Michael Gorlitzer, MD PhD — Hietzing Heart Center, Vienna, Austria
“We have used the vest for more than 6 months in more than 500 patients. We are very pleased with the results. Our deep sternal infection rate dropped by more than 70%.”
Hans Jonsson, MD PhD — Karolinska University Hospital, Stockholm, Sweden
“Since we treat all patients with the Posthorax sternum vest it is a win for all — we highly recommend Posthorax to every heart center.”
Prim. Univ. Doz. Martin Grabenwöger — Heart Center Vienna, Austria

Evaluating it for your unit?

We can supply the full papers, evaluation units for a ward trial, and pack pricing for cardiac and thoracic services.

For hospitals Request the PDFs

References

  1. Gorlitzer M, Wagner F, Pfeiffer S, et al. Prevention of sternal wound complications after sternotomy: results of a large prospective randomized multicentre trial. Interact Cardiovasc Thorac Surg. 2013;17(3):515–522.
  2. Gorlitzer M, Wagner F, Pfeiffer S, et al. A prospective randomized multicenter trial shows improvement of sternum related complications in cardiac surgery with the Posthorax support vest. Interact Cardiovasc Thorac Surg. 2010;10(5):714–718.
  3. Gorlitzer M, Folkmann S, Meinhart J, et al. A newly designed thorax support vest prevents sternum instability after median sternotomy. Eur J Cardiothorac Surg. 2009;36(2):335–339.
  4. Caimmi PP, Sabbatini M, Kapetanakis EI, et al. A randomized trial to assess the contribution of a novel thorax support vest (corset) in preventing mechanical complications of median sternotomy. Cardiol Ther. 2017;6(1):41–51.
  5. Caldonazo T, Dell’Aquila M, Doenst T, Gaudino M, et al. Thorax support vest to prevent sternal wound infections in cardiac surgery patients — a systematic review and meta-analysis. Interdiscip Cardiovasc Thorac Surg. 2024;38(4):ivae055.
  6. Spanish consensus document on the prevention and treatment of infection in cardiac surgery (SEICAV / SECTCV), 2021 — recommendation on postoperative sternal immobilisation systems. PMC8658224.

Items in “Beyond the randomised trials” that are not numbered above — Stockholm, Zurich, Southampton, Hamburg, the Maugeri cohort, the counter-pressure measurements and the twelve-study total — are quoted from the manufacturer’s published study register rather than from a paper we cite here. The register lists twelve studies in 12,512 patients across seven countries and we supply the individual papers on request; ask and we will name the source for any figure on this page.

How this page is prepared

Every claim on this page is traceable to a named, peer-reviewed publication listed below, and is stated in the terms the authors used — we do not round figures up or generalise beyond the endpoint that was measured. Where a number comes from a single trial, that trial is identified.

Posthorax Australia is the Australian distributor of the device, not the author of the research. We supply full PDFs on request so clinicians can read the primary sources rather than our summary of them. If you believe anything here misrepresents a paper, tell us and we will correct it.

Last reviewed 30 July 2026 · Corrections: sales@posthorax.com.au

Figures quoted on this page are those reported by the authors in the cited publications. Clinical decisions remain with the treating team; this page is provided as a reference for clinicians and informed patients, not as medical advice.